Sign In
Buy SEER
$1.86
-0.0100 (-0.535%)
At Close: Jun 03, 2026
Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
04:05pm, Wednesday, 06'th Aug 2025
Revenue grew 32% year-over-year, driven by increased product sales and service revenue Launched new high-throughput Proteograph ® ONE assay and SP200 automation instrument REDWOOD CITY, Calif., Aug.
Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference
04:05pm, Thursday, 31'st Jul 2025
REDWOOD CITY, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be parti
Seer to Report Second Quarter 2025 Financial Results on August 6, 2025
04:05pm, Tuesday, 22'nd Jul 2025
REDWOOD CITY, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial
Squarepoint Ops LLC Trims Stake in Seer, Inc. (NASDAQ:SEER)
03:34am, Wednesday, 11'th Jun 2025
Squarepoint Ops LLC reduced its position in shares of Seer, Inc. (NASDAQ:SEER – Free Report) by 46.3% during the 4th quarter, according to its most recent 13F filing with the Securities & Ex
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?
01:01pm, Tuesday, 10'th Jun 2025
Does Seer, Inc. (SEER) have what it takes to be a top stock pick for momentum investors? Let's find out.
First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics
REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteogra
Seer, Inc. (SEER) Q1 2025 Earnings Call Transcript
06:47pm, Tuesday, 13'th May 2025
Seer, Inc. (NASDAQ:SEER ) Q1 2025 Results Conference Call May 13, 2025 4:30 PM ET Company Participants Kelly Gura - Investor Relations Omid Farokhzad - Chief Executive Officer and Chair of the Board D
Seer, Inc. (SEER) Reports Q1 Loss, Tops Revenue Estimates
06:20pm, Tuesday, 13'th May 2025
Seer, Inc. (SEER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.37. This compares to loss of $0.32 per share a year ago.
Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook
04:05pm, Tuesday, 13'th May 2025
Revenue grew 37%, driven by increased product sales and service revenue Revenue grew 37%, driven by increased product sales and service revenue
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
04:05pm, Thursday, 24'th Apr 2025
REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it wi
SEER Engages First Block AI to Assist in its Carbon Division Launch and Funding as well as Develop and Create SEER Security and Utility Tokens Backed by Assets and Fully-Insured Biochar Carbon Credits
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER)
10:35am, Tuesday, 25'th Mar 2025
The heavy selling pressure might have exhausted for Seer (SEER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in re
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER)
10:35am, Monday, 24'th Mar 2025
Seer (SEER) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates coul
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround
10:35am, Thursday, 06'th Mar 2025
The heavy selling pressure might have exhausted for Seer (SEER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in re
